Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed from the page, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:29:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The government funding status banner was removed from the page; it previously warned about potential delays in updates.
    Difference
    0.3%
    Check dated 2025-11-17T19:13:09.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The DENIVOS study page shows only minor administrative edits, including formatting tweaks and an updated timestamp. There are no changes to core trial details, eligibility criteria, or the list of participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:16:31.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    - Added a government funding notice and open status details (affects trust and usage guidance). - Updated version from v3.1.0 to v3.2.0 and removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T04:14:34.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:38:56.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element was removed; no changes to pricing, stock, or time slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T09:54:34.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.